Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 249
- 试验地点
- 1
- 主要终点
- Overall patient satisfaction with intradermal vaccine
研究概览
简要总结
To assess the acceptance of the Fluzone Intradermal (ID)vaccine in adults and vaccine administrators in the United States. Patients completed 2 surveys, one immediately post-vaccination and one seven days later, that documented demographics and assessed their injection pain, injection anxiety, speed of injection, overall satisfaction, and preference for next year's vaccine. Vaccine administrators completed one survey assessing ease of vaccine preparation and administration, time required to administer, and safety/risk of needle stick injury for patient and administrator.
详细描述
Patients were divided into two groups: 1) those that reported receiving the intramuscular (IM) influenza vaccine in the past 3 years; and 2) those that reported not receiving the IM influenza vaccine in the past 3 years. The survey responses were compared between the two groups. In addition, the subjects that reported receiving the IM vaccine in the past 3 years were asked to compare their experience with the IM vaccine versus the ID vaccine.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 18 -64 years of age Desire to receive the Fluzone Intradermal vaccine to protect against influenza. -
排除标准
- •Less than 18 years of age, or 65 years of age and older. Desire to receive the Fluzone Intramuscular vaccine to protect against influenza.
- •problems of the immune system, current illness, severe allergy to eggs, severe (life threatening) allergies, history of having Guillain-Barre Syndrome (a severe paralytic illness) or having received a flu vaccine in the past three months.
结局指标
主要结局
Overall patient satisfaction with intradermal vaccine
时间窗: 7 days
Overall patient satisfaction was assessed immediately post-vaccination and seven days later by patient survey.
次要结局
- Overall satisfaction with the Fluzone ID vaccine by vaccine administrators(seven days)
研究者
James E. Foy, D.O.
Professor of Pediatrics, Touro University College of Osteopathic Medicine
Touro University, California